Off Patent
March 2027

Abilify

aripiprazole

Otsuka Pharmaceutical Co Ltd

Tablet (oral) · NDA 021436

Last listed protection ends
March 2, 2027

The FDA lists 2 patents for Abilify, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Ended
    Patent 9,125,939
    Claims a use (U-1749)
  2. Patent 8,759,350
    Claims a use (U-1529)